ERBB3 and head and neck squamous cell carcinoma: The protein level of HER3 was prematurely decreased to 52% of the original level at 4 h after inhibition of translational activity through cycloheximide in NOTCH1-knockdown SCCHN cells, and it further dropped to 28% at post-treatment 8 h.